Patient P-02031

Synthetic patientMETA-24 · Day 175 · 25–34 · F · baseline S12Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S12
Day 108 AD-05 recommended — Adherence Support AD-05
Day 109 Patient accepted — Started AD-05 in the companion
Day 114 GI symptom burden −14% vs expected — Adherence Support AD-05
Day 120 Tolerance state changed — Unstable → Improving
Day 136 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 136.

Primary contributors, last 14 days

Inflammatory activity-6
GI instability+4
Treatment adherence+4
Toxicity+4

What helped?

Adherence Support AD-05Day 108
Result: symptom burden −14%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

71 min

stable · +0.1 vs previous 14 d

Sleep duration

Wearable

7.3 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.4/10

stable · +0.3 vs previous 14 d

Steps

Wearable

7,622

stable · +125 vs previous 14 d

GI burden

Companion

10.3/100

worsening · +5.5 vs previous 14 d

Adherence

Companion

84.1 %

stable · -1.9 vs previous 14 d

Sleep quality

Wearable

54.5/100

stable · -2.3 vs previous 14 d

Glucose, CGM daily mean

CGM

125 mg/dL

stable · +2.4 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 84 from the failing basin, 34 from restoration.

Good elements to keep

Adherence Support AD-05
intervention · steering +24.2
Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +6.4
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -3.7 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Poor-sleep week
perturbation · steering -3
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Caffeine
-1.8no signal · 44%
Histamine load
+1no signal · 33%
Ultra-processed food
-0.9no signal · 23%
Dietary fat load
-0.7no signal · 22%
Simple carbohydrates
+0.6no signal · 20%
Alcohol
-0.5no signal · 17%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.9 · butyrate capacity 76/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 51 ms
Sleep: 7.4 h
Steps: 8,676
Resting HR: 59 bpm

Daily log: GI score 10, nutritional resilience 71, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02303	40%	S15	GI-04	improved	48
P-02355	40%	S09	GI-04	improved	55
P-02494	40%	S09	GI-04	improved	47
P-02218	39%	S01	DT-01	improved	61
P-02697	39%	S07	GI-04	improved	56
P-02235	38%	S14	DT-01	improved	50
P-02339	38%	S03	DT-01	improved	50
P-02391	38%	S19	HY-01	improved	53
P-02602	38%	S20	HY-01	improved	52
P-02645	38%	S02	HY-01	improved	56
P-02033	37%	S06	GI-04	improved	51
P-02082	37%	S12	NP-02	improved	53